Cargando…

Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level

PURPOSE: To explain the high inter-individual variability (IIV) and the frequency of exceeding the therapeutic reference range and the laboratory alert level of amisulpride, a population pharmacokinetic (PPK) model in Chinese patients with schizophrenia was built based on therapeutic drug monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shanqing, Li, Lu, Wang, Zhanzhang, Xiao, Tao, Li, Xiaolin, Liu, Shujing, Zhang, Ming, Lu, Haoyang, Wen, Yuguan, Shang, Dewei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449641/ https://www.ncbi.nlm.nih.gov/pubmed/34548782 http://dx.doi.org/10.2147/DDDT.S327506

Ejemplares similares

What to Do About Missed Doses? A Retrospective Study of Olanzapine in the Elderly
por: Xiao, Tao, et al.
Publicado: (2021)

Comprehensive Bibliometric Analysis of the Kynurenine Pathway in Mood Disorders: Focus on Gut Microbiota Research
por: Zhu, Xiuqing, et al.
Publicado: (2021)

Case Report: Predicting the Range of Lamotrigine Concentration Using Pharmacokinetic Models Based on Monte Carlo Simulation: A Case Study of Antiepileptic Drug-Related Leukopenia
por: Zhu, Xiuqing, et al.
Publicado: (2021)

Proteomics and weighted gene correlated network analysis reveal glutamatergic synapse signaling in diazepam treatment of alcohol withdrawal
por: Kong, Wan, et al.
Publicado: (2023)

Joint population pharmacokinetic modeling of venlafaxine and O-desmethyl venlafaxine in healthy volunteers and patients to evaluate the impact of morbidity and concomitant medication
por: Wang, Zhanzhang, et al.
Publicado: (2022)

Population pharmacokinetics model for escitalopram in Chinese psychiatric patients: effect of CYP2C19 and age
por: Liu, Shujing, et al.
Publicado: (2022)

Development and validation of an LC-MS/MS method by one-step precipitation for cinacalcet in human plasma
por: Lu, Haoyang, et al.
Publicado: (2023)

Bibliometric analysis of global research on the role of apolipoprotein E in Alzheimer's disease
por: Wang, Zhanzhang, et al.
Publicado: (2023)

Combining Metabolomics and Interpretable Machine Learning to Reveal Plasma Metabolic Profiling and Biological Correlates of Alcohol-Dependent Inpatients: What About Tryptophan Metabolism Regulation?
por: Zhu, Xiuqing, et al.
Publicado: (2021)

Bibliometric and Visual Analysis of Research on the Links Between the Gut Microbiota and Depression From 1999 to 2019
por: Zhu, Xiuqing, et al.
Publicado: (2021)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

Knowledge atlas of the involvement of glutamate and GABA in alcohol use disorder: A bibliometric and scientometric analysis
por: Wang, Zhanzhang, et al.
Publicado: (2022)

A machine learning approach to personalized dose adjustment of lamotrigine using noninvasive clinical parameters
por: Zhu, Xiuqing, et al.
Publicado: (2021)

An interpretable stacking ensemble learning framework based on multi-dimensional data for real-time prediction of drug concentration: The example of olanzapine
por: Zhu, Xiuqing, et al.
Publicado: (2022)

Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients
por: Zhu, Xiuqing, et al.
Publicado: (2022)

Safety and tolerability of antipsychotics: focus on amisulpride
por: Juruena, Mario F, et al.
Publicado: (2010)

Development and Validation of a Hydrophilic Interaction Liquid Chromatography Tandem Mass Spectrometry Method for the Determination of Asparagine in Human Serum
por: Lu, Haoyang, et al.
Publicado: (2020)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
por: Abdall-Razak, Ali, et al.
Publicado: (2019)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

Customized Reference Ranges for Laboratory Values Decrease False Positive Alerts in Intensive Care Unit Patients
por: Kilickaya, Oguz, et al.
Publicado: (2014)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
por: de Haan, Lieuwe, et al.
Publicado: (2023)

Amisulpride induced mania
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
por: Liu, Jin-Ling, et al.
Publicado: (2023)

Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function
por: Li, Anning, et al.
Publicado: (2023)

Rechallenge with Amisulpride in a Patient with Schizophrenia following a Manic Episode during Previous Therapy
por: Hu, Li-Yu, et al.
Publicado: (2022)

Effect of Peony-Glycyrrhiza Decoction on Amisulpride-Induced Hyperprolactinemia in Women with Schizophrenia: A Preliminary Study
por: Yang, Ping, et al.
Publicado: (2017)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open- label study
por: Herrera-Estrella, Miguel, et al.
Publicado: (2005)

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
por: Barnes, Thomas R.E., et al.
Publicado: (2018)

Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
por: Liang, Ying, et al.
Publicado: (2017)

Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia
por: Hu, Ze-Rui, et al.
Publicado: (2022)

The use of amisulpride in the treatment of acute psychosis
por: Nuss, Philippe, et al.
Publicado: (2007)

Delayed-onset akathisia due to amisulpride
por: Atmaca, Murad, et al.
Publicado: (2011)

Treatment of Burning Mouth Syndrome With Amisulpride
por: Rodriguez-Cerdeira, Carmen, et al.
Publicado: (2012)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8‐week, prospective, open‐label, multicenter, single‐arm study
por: Liang, Ying, et al.
Publicado: (2016)

Clinical Usefulness of Amisulpride Add-on Therapy in Schizophrenia Patients without Treatment Response to Second-generation Antipsychotics
por: Kang, Seung-Gul, et al.
Publicado: (2021)

Analysis of Gut Microbiota in Patients with Exacerbated Symptoms of Schizophrenia following Therapy with Amisulpride: A Pilot Study
por: Zheng, Jinchi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tpdelljm5g9ilahbkded9htu0f